tive visits between 9-15, 15-21, and 21-27 months after surgery were identified for 12-month, 18-month, and 24-month endpoints. All available data relating to the procedure, demographics, comorbidities, and prior surgical history were considered as potential predictors of %BMI loss. Regression models, using multiple model selection procedures, were fitted at each endpoint. RESULTS: The population consisted of 31,443 LAGB, 40,352 RYGB, and 2194 VSG patients, of whom 79% were female, 79% were Caucasian, and the mean age was 46 years. Of the total 73,989 patients, 26,920 had a 12-month endpoint, 7245 had an 18-month endpoint, and 1774 had a 24-month endpoint. Regression models explained 37 to 55% of the variance in %BMI loss, depending primarily on the endpoint, with the highest percent variance explained at the 12-month endpoint and the lowest at the 24month endpoint. Model selection methods made little difference in model fit. The type of bariatric surgery performed was the most significant predictor in all models. Other significant predictors in various models included key demographic variables and comorbidities, as well as baseline BMI. CONCLUSIONS: The data in the BOLD registry are sufficiently robust to enable the evaluation of predictors of bariatric surgery success including surgery type, comorbidities, baseline BMI and key demographic variables.
OBJECTIVES: Globally 80% cardiovascular disease deaths occurred in low and middle income countries with almost equal proportion inboth gender. Evidence shows that people in low and middle income countries are more exposed to cardiovascular risk factors while less exposed to preventivemeasures. It may lead to long course of management by either/ both medical and surgical techniques including coronary artery bypass surgery, increasing the economic burden.In order to find avenue for prevention, we aimed to measure the prevalence of cardiovascular risk factors among patients undergoing elective CABG in Karachi, Pakistan. METHODS: Information was collected through structured questionnaire and entered into Microsoft Access software. On the basis of research hypotheses, specific data chunk was extracted and analyzed in SPSS 19. RESULTS: In this retrospective chart review, 2073 patient undergoing elective CABG between January 2006 to June 2011 were included. Mean age of the patients was 54.85Ϯ9.7 years. Out of all, 14.7% patients were females.Family history was present in 53%, 47.7% were smokers. Conventional risk factors of overweight was 47.10%, obese was 14.7%,diabetes was 47.7%, hypertension was 69.50%, dyslipidemiawas 50.20%,renal failure was 9.2% and prior MI was 46.7%. Outcomes includeoperative mortality of 0.3% while14.8%, renal failure, 7% arrhythmias, 2.3% reoperation and 3.1% prolonged ventilation as postoperative complications. CONCLUSIONS: There is a high prevalence among patients undergoing elective CABG of coronary risk factors including dyslipidemia, hypertension, diabetes and smoking. 
SURGERY -Cost

OBJECTIVES:
The objective of this analysis is to assess impact on hospital costs for a patient using sugammadex for reversal of deep neuromuscular blockade compared to no reversal agent. METHODS: An economic model reflecting resource use and costs associated with neuromuscular block and its reversal, and residual blockade, was constructed for the Swedish healthcare setting. Sugammadex was compared to no reversal as other reversal agents are ineffective in reversing deep block. Clinical trial data were used to estimate time savings relating to shortened reversal in the operating room (OR). Costs of OR time were derived from labor costs for different types of OR staff. Resource use associated with clinical sequelae of residual blockade (aspiration, hypoxemia, muscle weakness, upper airway obstruction) was estimated from the literature, where available. Unit costs were taken from published pricelists of the state-owned pharmacy chain and, published hospital price lists. RESULTS: If all OR staff modeled (anesthetist, two surgeons and two nurses) can be re-allocated to realize time savings with shortened reversal, use of Sugammadex compared to no reversal of deep neuromuscular blockade is estimated to save ϳ353 SEK per reversed patient. This corresponds to an increase in drug costs of 1953 SEK, which is more than fully offset by a decrease in the costs of OR staff time and clinical sequelae of residual blockade (-2306 SEK) . In a worst case scenario, if only the anesthetist, one surgeon and one nurse realize time savings, costs would be increased (594 SEK) compared to no reversal. Results were sensitive to OR staff costs and time savings. CONCLUSIONS: Sugammadex for reversal of deep neuromuscular blockade can potentially lead to cost savings in the Swedish health care setting. The degree to which costs may be saved depends upon which OR staff are able to redeploy to other activities with shortened reversal.
PSU7 ECONOMIC BURDEN OF OBESITY AND THE IMPACT OF BARIATRIC SURGERY ON HEALTH CARE COSTS AND UTILIZATION
Yan C, Chuck A Institute of Health Economics, Edmonton, AB, Canada OBJECTIVES: This study was to estimate economic burden of obesity and to assess the impact of bariatric surgery on health care costs and utilization in adults in Alberta. METHODS: Multivariate regression models were developed to estimate the impact of BMI on physician, outpatient and inpatient costs and visits. A pre-post analysis over a 5-year period was conducted to compare the cost and visits before and after surgery. Patients who received bariatric surgery in 2006 were identified using the the Canadian Classification of Health Interventions (CCI) codes that correspond to bariatric surgery. Total physician, inpatient and outpatient costs and visits were calculated across all patients, over a period of two years before and two years after surgery. Health utilization data from Alberta provincial health administrative databases were linked with epidemiologic and demographic data contained in Canadian Community Health Survey (CCHS). RESULTS: When combining physician and outpatient costs, the mean estimate per obese resident was $696, following by $545 for overweight, $523 for underweight, and $480 for normal weight residents. Compared to normal weight, obesity, overweight and underweight were associated with increases of $217, $65 and $44, respectively. There were 217 bariatric surgery recipients in 2006. Health care costs and utilization two years presurgery were greater than two years post-surgery. The marginal change in health care costs and utilization between 2004 and 2005, however, was positive, indicating an increase prior to surgery. In contrast, the marginal change in health care costs and utilization was negative, indicating a decrease post-surgery. The estimate of total physician and hospital costs associated with bariatric surgery was $12,175.79 (SE: $586.75). CONCLUSIONS: Obesity placed a large economic burden on health care system. The bariatric surgery may alter the upward trajectory of health utilization for severely obese patients. Further research including longer follow-up period is necessary to confirm the impact of bariatric surgery.
PSU8 DISEASE BURDEN AND MEDICAL NEEDS IN OLDER PATIENTS WITH TOTAL KNEE ARTHROPLASTIES AND MUSCLE ATROPHY OR WEAKNESS
Green J 1 , Hallett L 1 , Zhao Y 2 , Birt J 2 , Foster T 1 1 United BioSource Corporation, Lexington, MA, USA, 2 Eli Lilly and Company, Inc., Indianapolis, IN, USA OBJECTIVES: Incidence of total knee arthroplasties (TKAs) increased from 31.2 to 220.9 per 100,000 person-years in the US from 1971-1976 to 2005-2008 . Muscle atrophy/weakness pre-or post-TKA surgery is associated with poor postoperative function. This review assessed disease burden and medical needs in older patients with TKA and muscle atrophy/weakness in US, Canada, Australia, and five major countries in Europe. METHODS: Using keywords related to muscle atrophy/weakness and TKA, we systematically searched English-language, MEDLINE-or EM-BASE-indexed literature published from May 2001 to May 2011 and materials available from governmental or professional organizations. Selected articles focused on epidemiologic, economic, humanistic, and treatment burden of muscle atrophy/ weakness (defined as evaluations of muscle atrophy, strength, or performance) in adults ages 50ϩ with TKA. Excluded articles were molecular and genetic studies, case reports, and evaluations of muscle atrophy/weakness in Ͻ20 patients. RESULTS: Eighty-three articles were included. Strength and function improve from preoperative baseline starting 3-4 months postoperatively but remain impaired compared with healthy controls. Postoperative physical therapy (PT), exercise, or electrical muscle stimulation improve strength and performance and accelerate recovery; however, operated limbs may never regain strength to match healthy controls or non-operated limbs. Preoperative exercise and education (Canada) or inpatient aquatic PT (Australia) do not reduce hospital length of stay versus usual care. Guidelines and real-world treatment pattern studies do not address optimal A74 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) A 1 -A 2 5 6
